Announcements Trials

Browse Landscape

Phase

Phase 1/2 2 Phase 3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 33 Small Cell Lung Carcinoma 16 Breast Neoplasms 13 Sarcoma 10 Carcinoma, Hepatocellular 8 Esophageal Squamous Cell Carcinoma 7 Lung Neoplasms 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Neoplasms 5 Carcinoma 5 Stomach Neoplasms 4 Pheochromocytoma 4 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Ovarian Epithelial 4 Thyroid Neoplasms 3 Recurrence 3 Paraganglioma 3 NSCLC 3 Glioma 3 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Platinum-resistant Ovarian Cancer 2 Ovarian Diseases 2

Interventions

Paclitaxel 34 Carboplatin 27 pembrolizumab 20 Bevacizumab 16 Letrozole 13 Megestrol Acetate 10 Cisplatin 9 lenvatinib 8 olaparib 7 dostarlimab 7 Metformin 7 durvalumab 6 abemaciclib 6 Radiotherapy 6 Everolimus 6 niraparib 5 Specimen Handling 5 Nivolumab 5 Medroxyprogesterone Acetate 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Fluorouracil 5 Docetaxel 5 Biopsy 5 temsirolimus 4 rucaparib 4 Oxaliplatin 4 Fulvestrant 4 Doxorubicin 4 sapanisertib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Endometrial Neoplasms × anlotinib × Clear all

NCT05550558 2022-09-28

CAN-RESPOND

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡